The Company
Press Releases
Awards & Grants
Working at Debiopharm
Corporate Responsibility
Drug Development
At a glance
Pipeline
Products
Publications
Leadership Team
Digital Health Investment
At a Glance
Portfolio
Startup funding
Leadership Team
Manufacturing, Research & Development
At a Glance
Technology pipeline
Leadership Team
Awards & Grants
Corporate Responsibility
Careers
Press Releases
Media
Manage cookies
Contact us
Share
Share
Home
Pipeline
naratuximab emtansine (Debio 1…
naratuximab emtansine (Debio 1562M)
Oncology
Anti-CD37 ADC/Multilink
